Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UiPath shares are trading higher Friday after the company posted better-than-expected second-quarter financial results after Th...
DA Davidson analyst Gil Luria maintains UiPath (NYSE:PATH) with a Neutral and raises the price target from $13 to $15.
TD Cowen analyst Bryan Bergin maintains UiPath (NYSE:PATH) with a Hold and lowers the price target from $17 to $16.
UiPath reported higher-than-expected Q2 results and raised fiscal guidance. Analysts praise signs of stability and improving ex...
Morgan Stanley analyst Keith Weiss assumes UiPath (NYSE:PATH) with a Equal-Weight rating and announces Price Target of $15.
RBC Capital analyst Matthew Hedberg reiterates UiPath (NYSE:PATH) with a Sector Perform and maintains $16 price target.
Barclays analyst Raimo Lenschow maintains UiPath (NYSE:PATH) with a Equal-Weight and raises the price target from $14 to $15.
Wells Fargo analyst Michael Turrin maintains UiPath (NYSE:PATH) with a Equal-Weight and raises the price target from $14 to ...
